Furthermore, an unintended tumor-protective effect of the apo-IDO1 inhibitor B37 has been recently described through an intrinsic upregulation of the JAK2/STAT3 pathway in mouse colon cancer cells CT26 (33). This evidence concerns the gene IDO1 and malignant colon neoplasm.